연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1797. Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for Radiosensitization.
Kim JH, Moon SH, No M, Kim JJ, Choi EJ, Cho BJ, Kim JS, Kim IH, Kim IA.
Cancer Res Treat. 2016 Jul;48(3):1130-40. doi: 10.4143/crt.2015.206. Epub 2015 Nov 17.
Link
1796. Clinical significance of midkine expression in sporadic desmoid tumors.
Kim HS, Kim J, Nam KH, Kim WH.
Oncol Lett. 2016 Mar;11(3):1677-1684. Epub 2016 Jan 19.
Link
1795. Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles.
Keam BS, Kim MK, Choi Y, Choi SJ, Choe PG, Lee KH, Kim TM, Kim TY, Oh DY, Kim DW, Im SA, Kim NJ, Heo DS, Park WB, Oh MD.
Cancer. 2016 Dec 20. doi: 10.1002/cncr.30468. [Epub ahead of print]
Link
1794. Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma.
Kim R, Keam BS, Kwon D, Ock CY, Kim M, Kim TM, Kim HJ, Jeon YK, Park IK, Kang CH, Kim DW, Kim YT, Heo DS.
World J Gastroenterol. 2016 Oct 7;22(37):8389-8397.
Link
1793. Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions.
Lee DW, Lee KH, Kim JW, Keam BS.
Int J Mol Sci. 2016 Jul 5;17(7). pii: E1074. doi: 10.3390/ijms17071074.
Link
1792. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
Ock CY, Keam BS, Kim TM, Han DH, Won TB, Lee SH, Hah JH, Kwon TK, Kim DW, Kim DY, Rhee CS, Wu HG, Sung MW, Heo DS.
Korean J Intern Med. 2016 May;31(3):570-8. doi: 10.3904/kjim.2015.020. Epub 2016 Mar 15.
Link
1791. PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
Ock CY, Kim S, Keam BS, Kim M, Kim TM, Kim JH, Jeon YK, Lee JS, Kwon SK, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS.
Oncotarget. 2016 Mar 29;7(13):15901-14. doi: 10.18632/oncotarget.7431.
Link
1790. Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study.
Kim R, Ock CY, Keam BS, Kim TM, Kim JH, Paeng JC, Kwon SK, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS.
BMC Cancer. 2016 Feb 17;16:116. doi: 10.1186/s12885-016-2147-y.
Link
1789. Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration.
Ock CY, Keam BS, Kim S, Lee JS, Kim M, Kim TM, Jeon YK, Kim DW, Chung DH, Heo DS.
Clin Cancer Res. 2016 May 1;22(9):2261-70. doi: 10.1158/1078-0432.CCR-15-2834. Epub 2016 Jan 27.
Link
1788. Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.
Ock CY, Son B, Keam BS, Lee SY, Moon J, Kwak H, Kim S, Kim TM, Jeon YK, Kwon SK, Hah JH, Lee SH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS.
J Cancer Res Clin Oncol. 2016 Apr;142(4):873-83. doi: 10.1007/s00432-015-2083-2. Epub 2015 Dec 16.
Link